Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4635605, 11 pages
https://doi.org/10.1155/2017/4635605
Research Article

Characterisation of Casein Kinase 1.1 in Leishmania donovani Using the CRISPR Cas9 Toolkit

1Institut Pasteur and INSERM U1201, Unité de Parasitologie Moléculaire et Signalisation, Paris, France
2Sir William Dunn School of Pathology, University of Oxford, Oxford, UK

Correspondence should be addressed to Najma Rachidi; rf.ruetsap@idihcar.amjan

Received 14 July 2017; Revised 22 September 2017; Accepted 12 October 2017; Published 29 November 2017

Academic Editor: Ernesto S. Nakayasu

Copyright © 2017 Daniel Martel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Pace, “Leishmaniasis,” Infection, vol. 69, supplement 1, pp. S10–S18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Galindo-Sevilla et al., “Low serum levels of dehydroepiandrosterone and cortisol in human diffuse cutaneous leishmaniasis by Leishmania mexicana,” Am J Trop Med Hyg, vol. 76, no. 3, pp. 566–572, 2007. View at Google Scholar
  3. S. M. Gossage, M. E. Rogers, and P. A. Bates, “Two separate growth phases during the development of Leishmania in sand flies: Implications for understanding the life cycle,” International Journal for Parasitology, vol. 33, no. 10, pp. 1027–1034, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Cantacessi, F. Dantas-Torres, M. J. Nolan, and D. Otranto, “The past, present, and future of Leishmania genomics and transcriptomics,” Trends in Parasitology, vol. 31, no. 3, pp. 100–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mondelaers, M. P. Sanchez-Cañete, S. Hendrickx et al., “Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes,” PLoS ONE, vol. 11, no. 4, p. e0154101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Ravooru, S. Ganji, N. Sathyanarayanan, and H. G. Nagendra, “Insilico analysis of hypothetical proteins unveils putative metabolic pathways and essential genes in Leishmania donovani,” Frontiers in Genetics, vol. 5, article 291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Alsford, D. J. Turner, S. O. Obado et al., “High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome,” Genome Research, vol. 21, no. 6, pp. 915–924, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Rico, A. Ivens, L. Glover, D. Horn, and K. R. Matthews, “Genome-wide RNAi selection identifies a regulator of transmission stage-enriched gene families and cell-type differentiation in Trypanosoma brucei,” PLoS Pathogens, vol. 13, no. 3, Article ID e1006279, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Beverley, “Protozomics: Trypanosomatid parasite genetics comes of age,” Nature Reviews Genetics, vol. 4, no. 1, pp. 11–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Dean, J. Sunter, R. J. Wheeler, I. Hodkinson, E. Gluenz, and K. Gull, “A toolkit enabling efficient, scalable and reproducible gene tagging in trypanosomatids,” Open Biology, vol. 5, no. 1, Article ID 140197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Dacher, M. A. Morales, P. Pescher et al., “Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses,” Molecular Microbiology, vol. 93, no. 1, pp. 146–166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. K. A. Robinson and S. M. Beverley, “Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania,” Molecular and Biochemical Parasitology, vol. 128, no. 2, pp. 217–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Cruz, C. M. Coburn, and S. M. Beverley, “Double targeted gene replacement for creating null mutants,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 88, no. 16, pp. 7170–7174, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. M. B. Rogers et al., “Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania,” Genome Res, vol. 21, no. 12, pp. 2129–2142, 2011. View at Google Scholar
  15. F. Dumetz, H. Imamura, M. Sanders et al., “Modulation of Aneuploidy in,” mBio, vol. 8, no. 3, p. e00599-17, 2017. View at Publisher · View at Google Scholar
  16. N. Lander, M. A. Chiurillo, and R. Docampo, “Genome Editing by CRISPR/Cas9: A Game Change in the Genetic Manipulation of Protists,” Journal of Eukaryotic Microbiology, vol. 63, no. 5, pp. 679–690, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Sollelis et al., “First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites,” Cell Microbiol, vol. 17, no. 10, pp. 1405–1412, 2015. View at Google Scholar
  18. W.-W. Zhang and G. Matlashewski, “CRISPR-Cas9-mediated genome editing in Leishmania donovani,” mBio, vol. 6, no. 4, Article ID e00861-15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Zhang, P. Lypaczewski, G. Matlashewski, and I. J. Blader, “Optimized CRISPR-Cas9 Genome Editing for Leishmania and Its Use To Target a Multigene Family, Induce Chromosomal Translocation, and Study DNA Break Repair Mechanisms,” mSphere, vol. 2, no. 1, 2017. View at Publisher · View at Google Scholar
  20. T. Beneke et al., “A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids,” R Soc Open Sci, vol. 4, no. 5, Article ID 170095, 2017. View at Google Scholar
  21. U. Knippschild, A. Gocht, S. Wolff, N. Huber, J. Löhler, and M. Stöter, “The casein kinase 1 family: Participation in multiple cellular processes in eukaryotes,” Cellular Signalling, vol. 17, no. 6, pp. 675–689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Knippschild, M. Krüger, J. Richter et al., “The CK1 family: Contribution to cellular stress response and its role in carcinogenesis,” Frontiers in Oncology, vol. 4, article no. 96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Dan-Goor, A. Nasereddin, H. Jaber, and C. L. Jaffe, “Identification of a secreted casein kinase 1 in Leishmania donovani: Effect of protein over expression on parasite growth and virulence,” PLoS ONE, vol. 8, no. 11, Article ID e79287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Silverman, J. Clos, C. C. De'Oliveira et al., “An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages,” Journal of Cell Science, vol. 123, no. 6, pp. 842–852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Rachidi, J. F. Taly, E. Durieu et al., “Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 3, pp. 1501–1515, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Durieu, E. Prina, O. Leclercq et al., “From drug screening to target deconvolution: a target-based drug discovery pipeline using Leishmania casein kinase 1 isoform 2 to identify compounds with antileishmanial activity,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 5, pp. 2822–2833, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. Dillon, K. Okrah, V. K. Hughitt et al., “Transcriptomic profiling of gene expression and RNA processing during Leishmania major differentiation,” Nucleic Acids Research, vol. 43, no. 14, pp. 6799–6813, 2015. View at Publisher · View at Google Scholar
  28. M. Fiebig, S. Kelly, E. Gluenz, and P. J. Myler, “Comparative life cycle transcriptomics revises Leishmania mexicana genome annotation and links a chromosome duplication with parasitism of vertebrates,” PLoS Pathogens, vol. 11, no. 10, Article ID e1005186, 2015. View at Publisher · View at Google Scholar
  29. H. Pawar, S. Renuse, S. N. Khobragade et al., “Neglected tropical diseases and omics science: Proteogenomics analysis of the promastigote stage of leishmania major parasite,” OMICS: A Journal of Integrative Biology, vol. 18, no. 8, pp. 499–512, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Saar, A. Ransford, E. Waldman et al., “Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani,” Molecular and Biochemical Parasitology, vol. 95, no. 1, pp. 9–20, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Goyard, H. Segawa, J. Gordon et al., “An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans,” Molecular and Biochemical Parasitology, vol. 130, no. 1, pp. 31–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Morales, R. Watanabe, C. Laurent et al., “Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages,” Proteomics, vol. 8, no. 2, pp. 350–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Schumann Burkard, P. Jutzi, and I. Roditi, “Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters,” Molecular and Biochemical Parasitology, vol. 175, no. 1, pp. 91–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Wheeler, E. Gluenz, and K. Gull, “Basal body multipotency and axonemal remodelling are two pathways to a 9+0 flagellum,” Nature Communications, vol. 6, article 8964, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Kemena and C. Notredame, “Upcoming challenges for multiple sequence alignment methods in the high-throughput era,” Bioinformatics, vol. 25, no. 19, pp. 2455–2465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Cong, F. A. Ran, D. Cox et al., “Multiplex genome engineering using CRISPR/Cas systems,” Science, vol. 339, no. 6121, pp. 819–823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Downing, H. Imamura, S. Decuypere et al., “Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance,” Genome Research, vol. 21, no. 12, pp. 2143–2156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Pescher, T. Blisnick, P. Bastin, and G. F. Späth, “Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation,” Cellular Microbiology, vol. 13, no. 7, pp. 978–991, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Peng and R. Tarleton, “EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens,” Microb Genom, vol. 1, no. 4, 2015. View at Google Scholar
  40. C. Branche, L. Kohl, G. Toutirais, J. Buisson, J. Cosson, and P. Bastin, “Conserved and specific functions of axoneme components in trypanosome motility,” Journal of Cell Science, vol. 119, no. 16, pp. 3443–3455, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. K. S. Ralston, A. G. Lerner, D. R. Diener, and K. L. Hill, “Flagellar motility contributes to cytokinesis in Trypanosoma brucei and is modulated by an evolutionarily conserved dynein regulatory system,” Eukaryotic Cell, vol. 5, no. 4, pp. 696–711, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. G. F. Spath and J. Clos, “Joining forces: first application of a rapamycin-induced dimerizable Cre system for conditional null mutant analysis in Leishmania,” Molecular Microbiology, vol. 100, no. 6, pp. 923–927, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Aslett et al., “TriTrypDB: a functional genomic resource for the Trypanosomatidae,” Nucleic Acids Res, 2010. View at Google Scholar
  44. M. D. Urbaniak, T. Mathieson, M. Bantscheff et al., “Chemical proteomic analysis reveals the drugability of the kinome of trypanosoma brucei,” ACS Chemical Biology, vol. 7, no. 11, pp. 1858–1865, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Gunasekera, D. Wüthrich, S. Braga-Lagache, M. Heller, and T. Ochsenreiter, “Proteome remodelling during development from blood to insect-form Trypanosoma brucei quantified by SILAC and mass spectrometry,” BMC Genomics, vol. 13, no. 1, article no. 556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. D. Urbaniak, “Casein kinase 1 isoform 2 is essential for bloodstream form Trypanosoma brucei,” Molecular and Biochemical Parasitology, vol. 166, no. 2, pp. 183–185, 2009. View at Publisher · View at Google Scholar · View at Scopus